Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Loss-making small-cap stocks in the Russell 2000 Index rose by 154%, while profitable companies increased by 34%.

Loss-making small-cap stocks in the Russell 2000 Index rose by 154%, while profitable companies increased by 34%.

AiCoinAiCoin2026/07/16 14:52
Show original
According to The Kobeissi Letter, companies with negative earnings per share in the Russell 2000 Index have risen 154% since mid-2025, while companies with positive earnings per share have increased 34%. Since the beginning of this year, unprofitable companies in the Russell 2000 Index have climbed 45%, and profitable companies have risen 18%. The Russell 2000 Index has gained 20% year-to-date, the S&P 500 Index is up 11%, and the "Magnificent Seven" tech stocks have risen 4%. The best-performing small-cap stocks are technology and infrastructure companies expected to benefit from AI spending.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.

Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.

智通财经•2026/09/29 03:11

Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request

A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.

智通财经•2026/09/29 02:46